Semaglutide
Semaglutide is a recombinant DNA produced polypeptide analog of human glucagon-like peptide-1 (GLP-1) which is used in combination with diet and exercise in the therapy of type 2 diabetes, either alone or in combination with other antidiabetic agents.
Online Inquiry
| CAT# | 10-101-325 |
| Chemical Structure |  |
| CAS | 910463-68-2 |
| Synonyms/Alias | Sermaglutide; UNII-53AXN4NNHX; NNC 0113-0217; 53AXN4NNHX |
| M.F/Formula | C187H291N45O59 |
| M.W/Mr. | 4113.57 |
| Application | The treatment of type 2 diabetes |
| Appearance | White to off-white powder |
| Purity | ≥ 98% (or refer to the Certificate of Analysis) |
| Activity | Agonist |
| Target | Glucagon Receptor |
Write a review
Ask a question
My Review for Semaglutide
Required fields are marked with *
×
Ask a Question for Semaglutide
Required fields are marked with *
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
